Maple Leaf Green World Inc.
TSX VENTURE : MGW

July 22, 2014 08:30 ET

Maple Leaf Submits Medical Marihuana Producer Application to Health Canada

CALGARY, ALBERTA--(Marketwired - July 22, 2014) - Maple Leaf Green World Inc. (TSX VENTURE:MGW) ("Maple Leaf" or the "Company") announces that under the direction of its consultant, Mr. Ivan Ross Vrana, the Company has submitted an application under the Marihuana for Medical Purposes Regulations ("MMPR") for licensed producer status. The Company expects to receive the initial feedback from Health Canada on its application within 4 to 6 weeks.

The Company has also joined the Canadian Medical Marihuana Association ("CNMMA") as a member. The CNMMA's mission is to ensure all Canadian patients who benefit from medical marijuana, have access to the high quality products and services, to meet their specific health care needs in a safe and well regulated environment. The association website is at www.cnmma.ca

There is no assurance that the Company will be qualified to obtain a producer licence and if so, will be able to obtain regulatory approvals for such licence. Additionally, there is no assurance that the Company will be able to acquire the required financing, assets or personnel to become a grower of medical marijuana, if licensed to do so.

For further information regarding Maple Leaf Green World Inc., visit www.mlgreenworld.com.

About Maple Leaf Green World Inc.

Maple Leaf is a Canadian company that focuses in the agricultural/environmental industry with three main areas of activity:

  1. Eco-Agriculture - Pursues several projects around the world. In China, it is focused on growing value-added tree seedlings and nursery products that assist with anti-desertification.
  2. Renewable Energy - Pursues various renewable energy projects around the world, including Yellowhorn in China which would provide valuable Yellowhorn seeds and ultimately oil from such seeds for the manufacture of bio-diesel fuel and premium healthy cooking oil.
  3. Canadian MMPR - Pursues opportunities within the medical cannabis industry. The Company is currently seeking a Canadian MMPR licensed producer status to grow medical cannabis in Canada for domestic consumption and export to approved countries.

Neither the TSX Venture Exchange or its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Certain statements in this news release including (i) statements that may contain words such as "anticipate", "could", "expect", "seek", "may" "intend", "will", "believe", "should", "project", "forecast", "plan" and similar expressions, including the negatives thereof, (ii) statements that are based on current expectations and estimates about the markets in which Maple Leaf operates and (iii) statements of belief, intentions and expectations about developments, results and events that will or may occur in the future, constitute "forward-looking statements" and are based on certain assumptions and analysis made by Maple Leaf. Forward-looking statements in this news release include, but are not limited to, statements with respect to future capital expenditures, including the amount, nature and timing thereof; other development trends within the agricultural industry, and status of, and ability to capitalize on, opportunities available to the Company and review business strategy; expansion and growth of Maple Leaf's business and operations and other such matters. Such forward-looking statements are subject to important risks and uncertainties, which are difficult to predict and that may affect Maple Leaf's operations, including, but are not limited to: the impact of general economic conditions; industry conditions; available equity or debt financing; government and regulatory developments including availability of requisite licences; product supply and demand; competition; and Maple Leaf's ability to attract and retain qualified personnel. Maple Leaf's actual results, performance or achievements could differ materially from those expressed in, or implied by, these forward-looking statements and, accordingly, no assurance can be given that any of the events anticipated by the forward-looking statements will transpire or occur, or if any of them do transpire or occur, what benefits Maple Leaf will derive there from.

Maple Leaf maintains a forward-looking statement database which is reviewed by management on a regular basis to ensure that no material change has occurred with respect to such forecasts. The Company will publicly disclose such material changes to its forward-looking statements as soon as they are known to management.

July 22, 2014 - $0.065

Contact Information